Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
22.34
-0.10 (-0.45%)
At close: Feb 21, 2025, 4:00 PM
22.33
-0.01 (-0.04%)
After-hours: Feb 21, 2025, 5:02 PM EST
Genmab Market Cap
Genmab has a market cap or net worth of $14.09 billion as of February 21, 2025. Its market cap has decreased by -24.22% in one year.
Market Cap
14.09B
Enterprise Value
11.28B
1-Year Change
-24.22%
Ranking
Category
Stock Price
$22.34
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $14.09B, an increase of 3,251.40%. That is a compound annual growth rate of 31.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 14.79B | 7.06% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 793.25B |
| UnitedHealth Group | 427.72B |
| Johnson & Johnson | 390.35B |
| Novo Nordisk | 370.84B |
| AbbVie | 357.92B |
| Abbott Laboratories | 234.43B |
| AstraZeneca | 229.50B |
| Merck & Co. | 225.15B |